CSL Ltd (CMXHF)
188.50
-3.50
(-1.82%)
USD |
OTCM |
Jun 14, 16:00
CSL Enterprise Value: 104.17B for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 104.17B |
| June 13, 2024 | 105.86B |
| June 12, 2024 | 103.20B |
| June 11, 2024 | 102.62B |
| June 10, 2024 | 103.70B |
| June 07, 2024 | 104.41B |
| June 06, 2024 | 105.86B |
| June 05, 2024 | 102.24B |
| June 04, 2024 | 103.56B |
| June 03, 2024 | 104.41B |
| May 31, 2024 | 104.41B |
| May 30, 2024 | 102.33B |
| May 29, 2024 | 103.47B |
| May 28, 2024 | 101.75B |
| May 24, 2024 | 100.56B |
| May 23, 2024 | 101.29B |
| May 22, 2024 | 101.29B |
| May 21, 2024 | 100.93B |
| May 20, 2024 | 102.78B |
| May 17, 2024 | 102.38B |
| May 16, 2024 | 104.89B |
| May 15, 2024 | 102.50B |
| May 14, 2024 | 100.54B |
| May 13, 2024 | 99.99B |
| May 10, 2024 | 100.18B |
| Date | Value |
|---|---|
| May 09, 2024 | 100.91B |
| May 08, 2024 | 100.91B |
| May 07, 2024 | 100.74B |
| May 06, 2024 | 98.87B |
| May 03, 2024 | 100.08B |
| May 02, 2024 | 98.22B |
| May 01, 2024 | 98.22B |
| April 30, 2024 | 98.49B |
| April 29, 2024 | 98.20B |
| April 26, 2024 | 98.03B |
| April 25, 2024 | 99.31B |
| April 24, 2024 | 99.31B |
| April 23, 2024 | 98.13B |
| April 22, 2024 | 98.13B |
| April 19, 2024 | 96.80B |
| April 18, 2024 | 96.80B |
| April 17, 2024 | 96.46B |
| April 16, 2024 | 97.64B |
| April 15, 2024 | 100.42B |
| April 12, 2024 | 100.42B |
| April 11, 2024 | 100.42B |
| April 10, 2024 | 104.05B |
| April 09, 2024 | 101.41B |
| April 08, 2024 | 100.32B |
| April 05, 2024 | 100.18B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
69.12B
Minimum
Jun 17 2019
116.89B
Maximum
Feb 03 2023
95.93B
Average
96.81B
Median
Aug 26 2022
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 3.883M |
| Immutep Ltd | -- |
| Opthea Ltd | 4.905M |
Enterprise Value Related Metrics
| Earnings Yield | 2.70% |
| Operating Earnings Yield | 2.76% |
| Normalized Earnings Yield | 2.700 |